Burt A. Adelman, Director at Verve Therapeutics, Inc. (VERV), bought 4,000 shares at $21.38 ($86K) on 2022-03-15, disclosed to the SEC on 2022-03-17.
Open-market purchase of $86k VERV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| DYAX | SELL | 2015-03-06 | $147K | — | Filing → |
| DYAX | SELL | 2015-01-05 | $1.1M | — | Filing → |
| DYAX | SELL | 2014-03-03 | $532K | — | Filing → |